Stay tuned for more information coming soon. Interested in showcasing your research? More details are coming soon—stay tuned! Dr. 

Come attend this month's virtual café talk to see the awesome work of Dr.

It’s not nostalgia; it’s a reminder that the biggest breakthroughs often come from re-seeing what we 🎥  Coming Soon: Live AMA with Dr.

Sharing the round table discussion with these excellent scientists felt like a dream come true, and Maria

Most biotech founders assume that failure comes from making the wrong call. A flawed experiment. creates the illusion of progress while direction quietly erodes. 👉 Biotech startup failure rarely comes

The most valuable outputs often come from the “wrong” projects.

Who should come This evening is open to pharma, biotech, academia, and students.

work in the field has been instrumental and is set to shape the future of drug discovery for years to come

acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won’t see coming

predict GPCR-ligand interactions based on input data of protein sequences and molecular fingerprints coming With the revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively collaboration of data across academia, industry, and regulatory bodies will likely increase in the coming

This property comes from the wide chemical space this reaction can access – we can substitute one reagent

Live AMAs and workshops are where the thinking comes alive, and where the question you've been sitting

Come check out our products or contact us for more information!

act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won’t see coming

Staying informed today prevents the delays others won’t see coming.

The next breakthroughs will come not from new receptors , but new ways of engaging and combining the

Acting on the right signals today shapes tomorrow’s breakthroughs — and prevents delays others won’t see coming

acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won’t see coming

act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won’t see coming

Legacy courses will migrate into this format over the coming weeks, with live courses returning in March

Predictive in vitro assays have dramatically reduced this attrition—but with success comes complacency

As 2025 comes to a close, this final edition of Weekly News focuses on how GPCR binding affinity experiments

GPCR Activation and Signaling Bias comes in layers.

Strong GPCR imaging tools come from strong interdisciplinary relationships.

Yet natural-product scaffolds come with costs: they are structurally complex, expensive to modify, often

expert training Unlock On-Demand Yearly Access Now — Premium Members Get Over 50% Discount at Checkout ➤ Coming

It’s when the tools you built in-house meet the problems no one saw coming. pHSense isn’t just a probe

The drug classes driving the questions The urgency behind all of this comes from the pipeline.

And when those pieces come together, the field jumps forward faster than any lab could push it alone.

That’s where pA₂ values  come in—a quick estimate of antagonist affinity from a single concentration.